-
1
-
-
17944374924
-
Task force for the D: Treatment of chronic heart failure ESoC. Guidelines for the diagnosis and treatment of chronic heart failure
-
Remme W.J., Swedberg K. Task force for the D: treatment of chronic heart failure ESoC. Guidelines for the diagnosis and treatment of chronic heart failure. Eur. Heart J. 22(17):2001;1527-1560
-
(2001)
Eur. Heart J.
, vol.22
, Issue.17
, pp. 1527-1560
-
-
Remme, W.J.1
Swedberg, K.2
-
2
-
-
0035195597
-
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)
-
Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J. Am. Coll. Cardiol. 38(7):2001;2101-2113
-
(2001)
J. Am. Coll. Cardiol.
, vol.38
, Issue.7
, pp. 2101-2113
-
-
Hunt, S.A.1
Baker, D.W.2
Chin, M.H.3
-
3
-
-
0037456942
-
Device therapy for heart failure
-
Boehmer J.P. Device therapy for heart failure. Am. J. Cardiol. 91(6A):2003;53D-59D
-
(2003)
Am. J. Cardiol.
, vol.91
, Issue.6 A
-
-
Boehmer, J.P.1
-
4
-
-
0037071808
-
Cardiac resynchronization in chronic heart failure
-
Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N. Engl. J. Med. 346(24):2002;1845-1853
-
(2002)
N. Engl. J. Med.
, vol.346
, Issue.24
, pp. 1845-1853
-
-
Abraham, W.T.1
Fisher, W.G.2
Smith, A.L.3
-
5
-
-
0033545652
-
The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: Rationale, design, and endpoints of a prospective randomized multicenter study
-
Auricchio A., Stellbrink C., Sack S., et al. The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study. Am. J. Cardiol. 83(5B):1999;130D-135D
-
(1999)
Am. J. Cardiol.
, vol.83
, Issue.5 B
-
-
Auricchio, A.1
Stellbrink, C.2
Sack, S.3
-
6
-
-
0035932533
-
Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay [comment]
-
Cazeau S., Leclercq C., Lavergne T., et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay [comment]. N. Engl. J. Med. 344(12):2001;873-880
-
(2001)
N. Engl. J. Med.
, vol.344
, Issue.12
, pp. 873-880
-
-
Cazeau, S.1
Leclercq, C.2
Lavergne, T.3
-
7
-
-
10744230456
-
Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias
-
Higgins S.L., Hummel J.D., Niazi I.K., et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J. Am. Coll. Cardiol. 42:2003;1454-1459
-
(2003)
J. Am. Coll. Cardiol.
, vol.42
, pp. 1454-1459
-
-
Higgins, S.L.1
Hummel, J.D.2
Niazi, I.K.3
-
8
-
-
0037638884
-
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD trial [comment]
-
Young J.B., Abraham W.T., Smith A.L., et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial [comment]. JAMA. 289(20):2003;2685-2694
-
(2003)
JAMA
, vol.289
, Issue.20
, pp. 2685-2694
-
-
Young, J.B.1
Abraham, W.T.2
Smith, A.L.3
-
9
-
-
2442479695
-
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
-
Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med. 350:2004;2140-2150
-
(2004)
N. Engl. J. Med.
, vol.350
, pp. 2140-2150
-
-
Bristow, M.R.1
Saxon, L.A.2
Boehmer, J.3
-
10
-
-
0006918490
-
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators
-
Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N. Engl. J. Med. 335(26):1996;1933-1940
-
(1996)
N. Engl. J. Med.
, vol.335
, Issue.26
, pp. 1933-1940
-
-
Moss, A.J.1
Hall, W.J.2
Cannom, D.S.3
-
11
-
-
0037149716
-
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
-
Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 346(12):2002;877-883
-
(2002)
N. Engl. J. Med.
, vol.346
, Issue.12
, pp. 877-883
-
-
Moss, A.J.1
Zareba, W.2
Hall, W.J.3
-
12
-
-
0033576804
-
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators
-
Buxton A.E., Lee K.L., Fisher J.D., et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N. Engl. J. Med. 341(25):1999;1882-1890
-
(1999)
N. Engl. J. Med.
, vol.341
, Issue.25
, pp. 1882-1890
-
-
Buxton, A.E.1
Lee, K.L.2
Fisher, J.D.3
-
13
-
-
0027998462
-
Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)
-
Doval H.C., Nul D.R., Grancelli H.O., et al. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet. 344(8921):1994;493-498
-
(1994)
Lancet
, vol.344
, Issue.8921
, pp. 493-498
-
-
Doval, H.C.1
Nul, D.R.2
Grancelli, H.O.3
-
14
-
-
0033616867
-
Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay
-
Kass D.A., Chen C.H., Curry C., et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation. 99(12):1999;1567-1573
-
(1999)
Circulation
, vol.99
, Issue.12
, pp. 1567-1573
-
-
Kass, D.A.1
Chen, C.H.2
Curry, C.3
-
15
-
-
0034687592
-
Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block
-
Nelson G.S., Berger R.D., Fetics B.J., et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation. 102(25):2000;3053-3059
-
(2000)
Circulation
, vol.102
, Issue.25
, pp. 3053-3059
-
-
Nelson, G.S.1
Berger, R.D.2
Fetics, B.J.3
-
16
-
-
0027211889
-
Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. the V-HeFT VA Cooperative Studies Group
-
Cohn J.N., Johnson G.R., Shabetai R., et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation. 87(6 Suppl):1993;VI5-VI16
-
(1993)
Circulation
, vol.87
, Issue.6 SUPPL.
-
-
Cohn, J.N.1
Johnson, G.R.2
Shabetai, R.3
-
17
-
-
0027154766
-
Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. the V-HeFT VA Cooperative Studies Group
-
Ziesche S., Cobb F.R., Cohn J.N., et al. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation. 87(6 Suppl):1993;VI56-VI64
-
(1993)
Circulation
, vol.87
, Issue.6 SUPPL.
-
-
Ziesche, S.1
Cobb, F.R.2
Cohn, J.N.3
-
18
-
-
0027365840
-
Efficacy of phosphodiesterase inhibition with milrinone in combination with converting enzyme inhibitors in patients with heart failure. the Milrinone Multicenter Trials Investigators
-
Colucci W.S., Sonnenblick E.H., Adams K.F., et al. Efficacy of phosphodiesterase inhibition with milrinone in combination with converting enzyme inhibitors in patients with heart failure. The Milrinone Multicenter Trials Investigators. J. Am. Coll. Cardiol. 22(4 Suppl A):1993;113A-118A
-
(1993)
J. Am. Coll. Cardiol.
, vol.22
, Issue.4 SUPPL. A
-
-
Colucci, W.S.1
Sonnenblick, E.H.2
Adams, K.F.3
-
19
-
-
0037433180
-
Cardiac resynchronization and death from progressive heart failure: A meta-analysis of randomized controlled trials [comment]
-
Bradley D.J., Bradley E.A., Baughman K.L., et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials [comment]. JAMA. 289(6):2003;730-740
-
(2003)
JAMA
, vol.289
, Issue.6
, pp. 730-740
-
-
Bradley, D.J.1
Bradley, E.A.2
Baughman, K.L.3
-
20
-
-
0001553408
-
The sudden cardiac death in heart failure trial: Pilot study [abstract]
-
Bardy G., Lee K., Mark D. The sudden cardiac death in heart failure trial: pilot study [abstract]. PACE. 20:1997;1148
-
(1997)
PACE
, vol.20
, pp. 1148
-
-
Bardy, G.1
Lee, K.2
Mark, D.3
-
21
-
-
0035879696
-
Prognostic implications of increased QRS duration in patients with moderate and severe left ventricular systolic dysfunction
-
A6
-
Silvet H., Amin J., Padmanabhan S., et al. Prognostic implications of increased QRS duration in patients with moderate and severe left ventricular systolic dysfunction. Am. J. Cardiol. 88(2):2001;182-185. A6
-
(2001)
Am. J. Cardiol.
, vol.88
, Issue.2
, pp. 182-185
-
-
Silvet, H.1
Amin, J.2
Padmanabhan, S.3
-
22
-
-
0033620875
-
Intraventricular conduction delay: A prognostic marker in chronic heart failure
-
Shamim W., Francis D.P., Yousufuddin M., et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int. J. Cardiol. 70(2):1999;171-178
-
(1999)
Int. J. Cardiol.
, vol.70
, Issue.2
, pp. 171-178
-
-
Shamim, W.1
Francis, D.P.2
Yousufuddin, M.3
-
23
-
-
0033860838
-
Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators
-
Bristow M.R., Feldman A.M., Saxon L.A. Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators. J. Card. Fail. 6(3):2000;276-285
-
(2000)
J. Card. Fail.
, vol.6
, Issue.3
, pp. 276-285
-
-
Bristow, M.R.1
Feldman, A.M.2
Saxon, L.A.3
-
24
-
-
3342971398
-
-
The American College of Cardiology Annual Scientific Sessions, New Orleans, LA, March 8
-
Bardy G. Sudden Cardiac Death Heart Failure Trial Results, The American College of Cardiology Annual Scientific Sessions, New Orleans, LA, March 8, 2004
-
(2004)
Sudden Cardiac Death Heart Failure Trial Results
-
-
Bardy, G.1
|